QNCX - Quince Therapeutics, Inc.
1.05
-0.040 -3.810%
Share volume: 939,587
Last Updated: 05-06-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.08%
PREVIOUS CLOSE
CHG
CHG%
$1.09
-0.04
-0.04%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-03-2023 | 11-14-2023 | 11-13-2024 | 05-13-2024 | 08-13-2024 | 11-13-2024 | 03-24-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 7.056 M | 5.584 M | 6.094 M | 8.408 M | 8.673 M | 8.842 M | 8.546 M | 10.109 M | |
| Selling general and admin | 3.826 M | 4.231 M | 4.663 M | 4.975 M | 4.971 M | 4.695 M | 3.630 M | 4.284 M | |
| Research and development | 3.230 M | 1.353 M | 1.431 M | 3.433 M | 3.702 M | 4.147 M | 4.916 M | 5.825 M | |
| Total expenses | 12.956 M | 5.584 M | 6.094 M | 9.986 M | 11.218 M | 28.192 M | 5.863 M | 12.012 M | |
| -56.90% | 9.13% | 63.87% | 12.34% | 151.31% | -79.20% | 104.88% | |||
| Operating income | -12.956 M | -5.584 M | -6.094 M | -9.986 M | -11.218 M | -28.192 M | -5.863 M | -12.012 M | |
| Ebit | -13.202 M | -5.691 M | -6.310 M | -9.519 M | -11.617 M | -28.101 M | -5.713 M | -12.530 M | |
| Pretax income | -12.502 M | -4.886 M | -5.351 M | -8.843 M | -11.118 M | -27.693 M | -5.479 M | -12.451 M | |
| -60.92% | 9.52% | 65.26% | 25.73% | 149.08% | -80.22% | 127.25% | |||
| Income tax | -248.000 K | 0.000 | 0.000 | 51.000 K | 31.000 K | 36.000 K | 13.000 K | 7.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -12.254 M | -4.886 M | -5.351 M | -8.894 M | -11.149 M | -27.729 M | -5.492 M | -12.458 M | |
| 60.13% | -9.52% | -66.21% | -25.35% | -148.71% | 80.19% | -126.84% |
